Botox For Overactive Bladder Treatment Approved By FDA

Expanded use of Botox (onabotulinumtoxinA) for the treatment of overactive bladder in adults who did not respond well to anticholinergics has been approved by the Food and Drug Administration (FDA). Anticholinergics are a class of medications that oppose the actions of acetylcholine, a neurotransmitter. These medications inhibit the transmission of parasympathetic nerve impulses; they reduce spasms of smooth muscles, such as the muscles in the bladder...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Urology / Nephrology Source Type: news